Eric Venker Roivant Sciences Ltd. (ROIV) insider trading activity
Eric Venker is President & Immunovant CEO of Roivant Sciences Ltd.. Currently has a direct ownership of 1.46 Million shares of ROIV, which is worth approximately $16.8 Million. The most recent transaction as insider was on Jun 09, 2023, when has been sold 299,384 shares (Common Shares) at a price of $3.85 per share, resulting in proceeds of $1,152,628. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.46M
30.98%
3M change
227.63%
12M change
Total Value Held
$16.8 Million
Eric Venker Transaction History
EV
Eric Venker
President & Immunovant CEO
London, X0